Pacira Biosciences
PCRX
Pacira Biosciences (PCRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Pacira Biosciences
's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pacira Biosciences - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -3.49% |
| 2022-12-31 | $0.28 B | -56.03% |
| 2021-12-31 | $0.65 B | 25.83% |
| 2020-12-31 | $0.52 B | 78.68% |
| 2019-12-31 | $0.29 B | -23.86% |
| 2018-12-31 | $0.38 B | 23.16% |
| 2017-12-31 | $0.31 B | 80.39% |
| 2016-12-31 | $0.17 B | 8.58% |
| 2015-12-31 | $0.15 B | 1.47% |
| 2014-12-31 | $0.15 B | 117.12% |
| 2013-12-31 | $72.15 M | 75.77% |
| 2012-12-31 | $41.05 M | -46.1% |
| 2011-12-31 | $76.15 M | 191.41% |
| 2010-12-31 | $26.13 M | 269.27% |
| 2009-12-31 | $7.07 M | -42.86% |
| 2008-12-31 | $12.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Omeros Corporation OMER | $0.31 B | 11.39% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Heron Therapeutics HRTX | $80.4 M | -71.14% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.10 B | -63.83% | 🇺🇸 USA |